Investar Holding (ISTR) Reaches $24.70 High on Jan, 14; 2 Analysts Are Bullish China Biologic Products Holdings, Inc. (CBPO) Last Week

January 14, 2018 - By Stephen Andrade

Among 2 analysts covering China Biologic Products (NASDAQ:CBPO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. China Biologic Products had 6 analyst reports since September 4, 2015 according to SRatingsIntel. Jefferies maintained China Biologic Products Holdings, Inc. (NASDAQ:CBPO) on Monday, June 12 with “Buy” rating. The stock has “Buy” rating by Jefferies on Tuesday, September 12. Jefferies maintained China Biologic Products Holdings, Inc. (NASDAQ:CBPO) on Friday, October 13 with “Buy” rating. On Thursday, August 3 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Jefferies given on Friday, September 4. See China Biologic Products Holdings, Inc. (NASDAQ:CBPO) latest ratings:

13/10/2017 Broker: Jefferies Rating: Buy New Target: $128.0 Maintain
12/09/2017 Broker: Jefferies Rating: Buy New Target: $128.0 Maintain
03/08/2017 Broker: Jefferies Rating: Buy New Target: $128.0000 Maintain

The stock of Investar Holding Corporation (NASDAQ:ISTR) reached all time high today, Jan, 14 and still has $25.44 target or 3.00% above today’s $24.70 share price. This indicates more upside for the $215.36 million company. This technical setup was reported by Barchart.com. If the $25.44 PT is reached, the company will be worth $6.46M more. The stock increased 0.20% or $0.05 during the last trading session, reaching $24.7. About 12,996 shares traded or 2.27% up from the average. Investar Holding Corporation (NASDAQ:ISTR) has risen 48.68% since January 14, 2017 and is uptrending. It has outperformed by 31.98% the S&P500.

Among 3 analysts covering Investar (NASDAQ:ISTR), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Investar had 4 analyst reports since August 26, 2016 according to SRatingsIntel. PiperJaffray reinitiated Investar Holding Corporation (NASDAQ:ISTR) on Thursday, October 5 with “Overweight” rating. The stock has “Buy” rating by Piper Jaffray on Thursday, July 27. The firm has “Market Perform” rating given on Thursday, August 10 by Raymond James. On Friday, August 26 the stock rating was initiated by Raymond James with “Outperform”.

Analysts await Investar Holding Corporation (NASDAQ:ISTR) to report earnings on January, 25. They expect $0.32 earnings per share, up 23.08% or $0.06 from last year’s $0.26 per share. ISTR’s profit will be $2.79 million for 19.30 P/E if the $0.32 EPS becomes a reality. After $0.29 actual earnings per share reported by Investar Holding Corporation for the previous quarter, Wall Street now forecasts 10.34% EPS growth.

Investar Holding Corporation operates as the bank holding firm for Investar Bank that provides a range of commercial banking products for individuals and small to medium-sized businesses in South Louisiana. The company has market cap of $215.36 million. It accepts various deposit services and products, such as savings, checking, money market, NOW, and individual retirement accounts, as well as various certificates of deposit; debit cards; and mobile banking services. It has a 25.54 P/E ratio. The firm also offers multifamily, farmland, and commercial real estate loans; loans for the construction of commercial projects, and single family residential and multifamily properties; commercial and industrial loans, including working capital lines of credit and equipment loans; consumer loans comprising secured and unsecured installment and term loans, second mortgages, and home equity loans and lines of credit, as well as auto loans; and one-to-four family residential real estate loans consisting of second and other mortgage loans.

Investors sentiment decreased to 0.03 in Q3 2017. Its down 0.62, from 0.65 in 2017Q2. It dived, as 88 investors sold China Biologic Products Holdings, Inc. shares while 1 reduced holdings. 0 funds opened positions while 3 raised stakes. 1.23 million shares or 91.95% less from 15.29 million shares in 2017Q2 were reported. Jupiter Asset Mngmt Limited has invested 0.51% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Matthews Limited Liability Corp has invested 0.16% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Pub Employees Retirement Sys Of Ohio invested 0.01% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). 1.02 million were accumulated by Schroder Inv Management Grp Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: